Elevated plasma chromogranin-A concentrations in prostatic carcinoma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1856931.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chromogranin-A is considered a sensitive immunohistochemical tissue marker in neuroendocrine prostatic carcinoma. We report that the plasma chromogranin-A level was elevated in 48% of 25 patients with stage D2 prostate cancer, and suggest that this marker can be used to monitor the clinical course of these patients.
Medical subject headings
- Carcinoma
- Chromogranins
- Prostatic Neoplasms